40 results
Page 2 of 2
8-K
EX-99.1
4wvbi0kbjj7y9z
30 Mar 20
Processa Pharmaceuticals to Move Forward with a PCS499 Phase 3 Trial after a Successful Fda Meeting
4:00pm
8-K
EX-99.1
jfggxb
17 Mar 20
Processa Pharmaceuticals Announces Results from the Phase 2 Study In Necrobiosis Lipoidica
9:30am
424B3
3rm6f
13 Nov 18
Prospectus supplement
9:39pm
424B3
ej48k6vzu9wq 6cpn
9 Nov 18
Prospectus supplement
5:04pm
CORRESP
pqhqh6wfabuxk3p
30 Oct 18
Correspondence with SEC
12:00am
UPLOAD
vmscrxa1pjud zob
24 Oct 18
Letter from SEC
12:00am
8-K
EX-99.1
n8mdw8
3 Oct 18
Processa Pharmaceuticals Receives Fda Clearance
12:00am
8-K
EX-99.1
3h4ngramyhha2mle 7s8
30 Mar 18
License for the Clinical Stage Compound CTP-499 and Plans to Develop
12:00am